Posted on

Donepezil hydrochloride [23 mg film-coated tablet] for first-line therapy for moderate to severe Alzheimer’s Disease (AD)

Cycle 2 | Drugs

HTA Council Recommendation (as of 12 November 2024 )

As final recommendation, the HTA Council recommends donepezil hydrochloride [23 mg film-coated tablet] for first-line therapy for moderate to severe Alzheimer’s Disease (AD) for government financing

Relevant Information

  • Status: With Final HTA Council Recommendation and SOH Decision
  • Topic Assignment: Internal Assessment
  • Policy Question: Should donepezil hydrochloride [23 mg film-coated tablet] for first-line therapy for moderate to severe Alzheimer’s Disease (AD) be funded by the government?
  • Secretary of Health Decision: Approved on 11 December 2024

Evidence and Relevant Documents

Back to Assessments Page